Spots Global Cancer Trial Database for ruxolitinib phosphate
Every month we try and update this database with for ruxolitinib phosphate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis | NCT02528877 | Acute Myeloid L... Primary Myelofi... Primary Myelofi... Secondary Acute... Secondary Myelo... | Allogeneic Bone... Allogeneic Hema... Fludarabine Pho... Laboratory Biom... Melphalan Peripheral Bloo... Pharmacological... Ruxolitinib Pho... Sirolimus Tacrolimus | 18 Years - 75 Years | City of Hope Medical Center | |
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia | NCT02779283 | Acute Lymphobla... Acute Myeloid L... | Cyclophosphamid... Cytarabine Dasatinib Dexamethasone Doxorubicin Hyd... Idarubicin Idelalisib In Vitro Kinase... Leucovorin Calc... Methotrexate Methylprednisol... Ponatinib Hydro... Rituximab Ruxolitinib Pho... Sorafenib Tosyl... Sunitinib Malat... Vincristine Sul... | 18 Years - 64 Years | OHSU Knight Cancer Institute | |
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome | NCT06128070 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... | Biospecimen Col... Chest Computed ... Echocardiograph... Hematopoietic C... Methotrexate Multigated Acqu... Ruxolitinib Pho... Tacrolimus | 2 Years - 22 Years | City of Hope Medical Center | |
Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia | NCT02420717 | Recurrent B Acu... Recurrent Ph-Li... Refractory B Ac... Refractory Ph-L... | Cyclophosphamid... Cytarabine Dasatinib Dexamethasone Doxorubicin Laboratory Biom... Leucovorin Mercaptopurine Methotrexate Prednisone Rituximab Ruxolitinib Pho... Vincristine | 10 Years - | M.D. Anderson Cancer Center | |
Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia | NCT02131584 | Chronic Lymphoc... | Questionnaire A... Ruxolitinib Pho... | 18 Years - | M.D. Anderson Cancer Center | |
Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer | NCT03012230 | Metastatic Mali... Stage IV Breast... Triple-Negative... | Laboratory Biom... Pembrolizumab Ruxolitinib Pho... | 18 Years - | Mayo Clinic | |
Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant | NCT01431209 | Recurrent Diffu... Recurrent Matur... Refractory Diff... Refractory Matu... | Laboratory Biom... Ruxolitinib Pho... | 18 Years - | University of Nebraska | |
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome | NCT06128070 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... | Biospecimen Col... Chest Computed ... Echocardiograph... Hematopoietic C... Methotrexate Multigated Acqu... Ruxolitinib Pho... Tacrolimus | 2 Years - 22 Years | City of Hope Medical Center | |
Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia | NCT02092324 | Atypical Chroni... Chronic Neutrop... | Laboratory Biom... Quality-of-Life... Questionnaire A... Ruxolitinib Pho... | 18 Years - | OHSU Knight Cancer Institute |